Open access
Open access
Powered by Google Translator Translator

Vaccines

The next generation of coronavirus vaccines: a graphical guide

3 Feb, 2023 | 14:18h | UTC

The next generation of coronavirus vaccines: a graphical guide – Nature

 


WHO updates recommendations on HPV vaccination schedule

9 Jan, 2023 | 14:57h | UTC

News Release: WHO updates recommendations on HPV vaccination schedule – World Health Organization

Guideline: Human papillomavirus vaccines: WHO position paper, December 2022 – World Health Organization

Commentaries: 

WHO Recommends One HPV Vaccine Dose Instead of Two; Move Should Help Expand Coverage – Health Policy Watch

WHO supports 1-dose HPV vaccine strategy – CIDRAP

 

Commentary on Twitter

 


RCTs | Vaccines for Zaire Ebola virus disease.

16 Dec, 2022 | 13:46h | UTC

Randomized Trial of Vaccines for Zaire Ebola Virus Disease – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Ebola vaccine regimens safe, immunogenic in adults and children – NIH News Releases

Commentaries: 

Ebola vaccine strategies show safety and immune response – CIDRAP

Trial on safety and immunogenicity of Ebola vaccines yields promising results – Institut National de la Sante et de la Recherche Medicale

 

Commentary on Twitter

 


Review | Human papillomavirus vaccination and cervical cancer risk.

16 Dec, 2022 | 13:26h | UTC

Human papillomavirus vaccination and cervical cancer risk – The BMJ

 


SR | Efficacy and safety of COVID‐19 vaccines.

8 Dec, 2022 | 13:04h | UTC

Efficacy and safety of COVID‐19 vaccines – Cochrane Library

Summary: What are the benefits and risks of vaccines for preventing COVID-19? – Cochrane Library

Commentary: Are COVID-19 vaccines effective and safe? New Cochrane evidence – Evidently Cochrane

 


Case-control study | Effectiveness of COVID-19 vaccines against infection and mortality in children in Argentina.

2 Dec, 2022 | 14:36h | UTC

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study – The BMJ

 


M-A | Efficacy and safety of COVID-19 inactivated vaccine.

1 Dec, 2022 | 14:00h | UTC

Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis – Frontiers in Medicine

 


Joint consensus statement on the vaccination of adult and pediatric hematopoietic stem cell transplant recipients.

30 Nov, 2022 | 13:39h | UTC

Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children’s cancer and Leukaemia Group (CCLG), and British Infection Association (BIA) – Journal of Infection

 


M-A | Cardioprotective effects of influenza vaccination in patients with high risk of cardiovascular disease.

25 Nov, 2022 | 12:47h | UTC

Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis – European Journal of Preventive Cardiology (free for a limited period)

Related:

RCT | Influenza vaccine to reduce adverse vascular events in patients with heart failure.

RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination.

 


RCT | Influenza vaccine to reduce adverse vascular events in patients with heart failure.

18 Nov, 2022 | 13:26h | UTC

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial – The Lancet Global Health

Commentary: 

Flu vaccines cut pneumonia, cardiovascular issues in heart failure patients – CIDRAP

Flu Shot Could Be Lifesaver for Folks With Heart Failure – HealthDay

 


RCT | Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age.

20 Oct, 2022 | 12:35h | UTC

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age – New England Journal of Medicine

 

Commentary on Twitter

 


Myocarditis after BNT162b2 vaccination in Israeli adolescents.

20 Oct, 2022 | 12:34h | UTC

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents – New England Journal of Medicine

 

Commentary on Twitter

 


Pooled analysis of cohort studies | Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters.

19 Oct, 2022 | 14:28h | UTC

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales – The Lancet

Commentaries:

Prioritisation of COVID-19 boosters in the omicron era – The Lancet

COVID booster halved severe illness, but some groups still at higher risk – CIDRAP

 


Case-control study | Odds of hospitalization for COVID-19 after 3 vs. 2 doses of mRNA vaccine by time since booster dose.

19 Oct, 2022 | 14:27h | UTC

Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose – JAMA

News Release: Study indicates COVID-19 boosters among vaccinated individuals significantly reduce hospitalization rates – Providence Health & Services

 


Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the US.

13 Oct, 2022 | 13:51h | UTC

Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States – Annals of Internal Medicine

News Release: Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children, younger adults in the US – American College of Physicians

 

Commentary on Twitter (thread – click for more)

 

Commentary on Twitter

 


RCT | Immunogenicity and safety of one-dose human papillomavirus vaccine vs. two or three doses.

29 Sep, 2022 | 13:21h | UTC

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial – The Lancet Global Health

Invited Commentary: HPV vaccines: when one plus one equals three – The Lancet Global Health

Related:

RCT: Single-dose HPV vaccination found effective among young African women.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Opinion: A Single-dose HPV Vaccine Would Have a Big Impact on Cancer Prevention

Another Observational Study Suggests One Dose of HPV Vaccine may be Enough

Another Study Suggesting One Dose of HPV Vaccine may be Effective for Prevention of Cervical Cancer

Comparison of different human papillomavirus (HPV) vaccines and the number of doses administered to prevent HPV-related disease in females and males – Cochrane Library

Large Observational Study Suggests One Dose of HPV Vaccine May Be as Effective as Three

 


Impact of routine childhood immunization in reducing vaccine-preventable diseases in the US.

21 Sep, 2022 | 13:11h | UTC

Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the United States – Pediatrics

 


RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination.

13 Sep, 2022 | 13:19h | UTC

Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial – European Heart Journal

 

Commentary on Twitter

 


Study raises concerns about the effectiveness of the monkeypox vaccine.

6 Sep, 2022 | 14:39h | UTC

Study raises concerns about the effectiveness of the monkeypox vaccine – STAT

Original Study (Preprint): Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals – medRxiv

 


FDA authorizes updated COVID boosters from Moderna and Pfizer.

5 Sep, 2022 | 14:36h | UTC

FDA authorizes updated COVID boosters from Moderna and Pfizer – CIDRAP

FDA News Release: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose – U.S. Food & Drug Administration

 


Review | Covid-19 vaccines — immunity, variants, boosters.

1 Sep, 2022 | 11:57h | UTC

Covid-19 Vaccines — Immunity, Variants, Boosters – New England Journal of Medicine

 


Long-term follow up of a RCT | Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine.

24 Aug, 2022 | 13:53h | UTC

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Clinical Unmasking May Cause Increased Rates of High-Grade Cervical Neoplasia From Non–Vaccine Preventable HPV – Cancer Network

 

Commentary on Twitter

 


WHO Guidance | Behavioral and social drivers of vaccination: tools and practical guidance for achieving high uptake.

22 Aug, 2022 | 12:13h | UTC

Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake – World Health Organization

 


UK approves updated Moderna vaccine targeting Omicron variant.

16 Aug, 2022 | 13:49h | UTC

UK approves updated Moderna vaccine targeting Omicron variant – Associated Press/MedicalXpress

See also: Covid: UK first country to approve dual-strain vaccine – BBC

 


M-A | Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course.

15 Aug, 2022 | 12:21h | UTC

Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis – The Lancet Global Health

Invited Commentary: Infant BCG vaccination is beneficial, but not sufficient – The Lancet Global Health

News Release: BCG vaccine prevents tuberculosis in young children, but not adults – Boston University School of Public Health

 

Commentary from the author on Twitter (thread – click for more)

 


Stay Updated in Your Specialty

No spam, just news.